NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ABIVAX Société Anonyme (PA: ABVX)

 
ABVX Technical Analysis
5
As on 22nd Dec 2025 ABVX STOCK Price closed @ 115.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 25.31 & Strong Buy for SHORT-TERM with Stoploss of 6.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABVXSTOCK Price

Open 105.40 Change Price %
High 117.40 1 Day 15.40 15.40
Low 105.00 1 Week -0.40 -0.35
Close 115.40 1 Month 23.90 26.12
Volume 389668 1 Year 107.71 1400.65
52 Week High 115.80 | 52 Week Low 4.56
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
LAT 0.02 %
ALBOO 0.00 %
SIGHT 0.10 0.00%
ALADO 0.00 %
ALRPD 0.00 %
CGG 0.69 -2.82%
ALHYG 0.01 0.00%
ALTBG 2.88 8.27%
 
PA France Top Gainers Stocks
MLFTI 0.06 50.00%
AFME 2.01 40.56%
MLSML 0.05 25.00%
MLSRP 38.00 18.01%
ALMDT 4.57 17.78%
ALSAS 5.15 15.47%
ABVX 115.40 15.40%
ALINV 0.90 12.50%
OREGE 0.30 11.11%
JCQ 19.90 9.94%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
MLNMA 0.02 -33.33%
FPN 0.02 -33.33%
MLWEA 1.64 -25.45%
ALDBT 0.03 -25.00%
ALMET 2.26 -12.40%
MLCLP 1.23 -12.14%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
 
 
ABVX
Daily Charts
ABVX
Intraday Charts
Whats New @
Bazaartrend
ABVX
Free Analysis
 
ABVX Important Levels Intraday
RESISTANCE139.29
RESISTANCE131.63
RESISTANCE126.89
RESISTANCE122.16
SUPPORT108.64
SUPPORT103.91
SUPPORT99.17
SUPPORT91.51
 
ABVX Forecast December 2025
4th UP Forecast118.64
3rd UP Forecast117.6
2nd UP Forecast116.96
1st UP Forecast116.32
1st DOWN Forecast114.48
2nd DOWN Forecast113.84
3rd DOWN Forecast113.2
4th DOWN Forecast112.16
 
ABVX Weekly Forecast
4th UP Forecast116.85
3rd UP Forecast116.38
2nd UP Forecast116.10
1st UP Forecast115.81
1st DOWN Forecast114.99
2nd DOWN Forecast114.70
3rd DOWN Forecast114.42
4th DOWN Forecast113.95
 
ABVX Forecast2025
4th UP Forecast350.67
3rd UP Forecast275.22
2nd UP Forecast228.58
1st UP Forecast181.94
1st DOWN Forecast48.86
2nd DOWN Forecast2.22
3rd DOWN Forecast-44.42
4th DOWN Forecast-119.87
 
 
ABVX Other Details
Segment EQ
Market Capital 494349600.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABVX Address
ABVX
 
ABVX Latest News
 
Your Comments and Response on ABIVAX Société Anonyme
 
ABVX Business Profile
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer. In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France. Address: 5, rue de la Baume, Paris, France, 75008
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service